BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3000827)

  • 1. The heparin-binding site(s) of histidine-rich glycoprotein as suggested by sequence homology with antithrombin III.
    Koide T; Foster D; Odani S
    FEBS Lett; 1986 Jan; 194(2):242-4. PubMed ID: 3000827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histidine-rich glycoprotein does not interfere with interactions between antithrombin III and heparin-like compounds on vascular endothelial cells.
    Shimada K; Kawamoto A; Matsubayashi K; Ozawa T
    Blood; 1989 Jan; 73(1):191-3. PubMed ID: 2910359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of heparin with histidine-rich glycoprotein and with antithrombin III.
    Lijnen HR; van Hoef B; Collen D
    Thromb Haemost; 1983 Aug; 50(2):560-2. PubMed ID: 6415849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein.
    Kluszynski BA; Kim C; Faulk WP
    J Biol Chem; 1997 May; 272(21):13541-7. PubMed ID: 9153200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding.
    Burch MK; Blackburn MN; Morgan WT
    Biochemistry; 1987 Nov; 26(23):7477-82. PubMed ID: 3427089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
    Brown KJ; Parish CR
    Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the domain structure of antithrombin III. Tentative localization of the heparin binding region using 1H NMR spectroscopy.
    Gettins P; Wooten EW
    Biochemistry; 1987 Jul; 26(14):4403-8. PubMed ID: 3663595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of heparin with histidine-rich glycoprotein.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1989; 556():181-5. PubMed ID: 2660685
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human histidine-rich glycoprotein: simultaneous purification with antithrombin III and characterization of its gross structure.
    Koide T; Odani S; Ono T
    J Biochem; 1985 Nov; 98(5):1191-200. PubMed ID: 4086476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin-heparin affinity reduced by fucosylation of carbohydrate at asparagine 155.
    Garone L; Edmunds T; Hanson E; Bernasconi R; Huntington JA; Meagher JL; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(27):8881-9. PubMed ID: 8688424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial glycosylation of antithrombin III asparagine-135 is caused by the serine in the third position of its N-glycosylation consensus sequence and is responsible for production of the beta-antithrombin III isoform with enhanced heparin affinity.
    Picard V; Ersdal-Badju E; Bock SC
    Biochemistry; 1995 Jul; 34(26):8433-40. PubMed ID: 7599134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III and its interaction with heparin. Comparison of the human, bovine, and porcine proteins by 1H NMR spectroscopy.
    Gettins P
    Biochemistry; 1987 Mar; 26(5):1391-8. PubMed ID: 3567176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal sequence of human plasma histidine-rich glycoprotein homologous to antithrombin with high affinity for heparin.
    Koide T; Odani S; Ono T
    FEBS Lett; 1982 May; 141(2):222-4. PubMed ID: 7095150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.